[1] Blackstock AW, Momex F, Partensky C,et al.Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer a phaseⅡ study
[J].British J Cancer, 2006,95(3):260-265.
[2] 孙 燕.内科肿瘤学 [M].北京:人民卫生出版社,2001:226-227.
[3] 张群华,倪泉兴.胰腺癌2340例临床病例分析 [J].中华医学杂志,2004,84 (3):73-75.
[4] Andrerr Sandberg A,Westerdhal J,Ihse I.Recurrence after pancreatectomy for pancreatic carcinoma[J].Digestion,1992,52(4):67-72.
[5] 于会明,刘运芳,于金明.三维适形放疗联合者西他滨治疗局部晚期胰腺癌的疗效分析[J].中华放射肺病学杂志,2006, 15(1):55-56.
[6] Li CP,Chao Y,Chi KH,et al.Concurrent chemoradiotherapy treament of locally advanced pancreatic cancer gemcitabine versus 5-fluorouracil a randomized
controlled study[J].Int J Radiat Oncol BiolPhys,2003,57(1):98-104.
[7] Thomas B Brunner, Gerhard G Grabenbauer, Peterklein,et al.PhaseⅠtrial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy
in pationts with locally advanced pancreatic cancer[J].Int J Radiat Oncol BiolPhys,2003,55(1):144-153.
[8] 龚继芳,张晓东,李 洁,等.吉西他滨为基础的化疗方案治疗进展期胰腺癌临床研究 [J].癌症,2007,26 (8):890-894.
[9] 夏廷毅.γ(X)线立体定向放射治疗临床应用规范和治疗进展 [J].中国癌症杂志,2006,16 (6):454-458.
[1]江晓肖,宋水川,陈达伟.伽玛刀治疗对胰腺癌患者外周T淋巴细胞亚群的影响[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):129.
JIANG Xiao-xiao,SONG Shui-chuan,CHEN Da-wei..Clinical analysis of immunological effects on pancreatic cancer patients by γ-knife therapy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(03):129.
[2]谢荣臻,曾祥福,邓伟,等.miR-10a在胰腺癌侵袭转移中的作用[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):352.[doi:10.3969/j.issn.1672-271X.2017.04.005]
XIE Rong-zhen,ZENG Xiang-fu,DENG Wei,et al.The role of miR-10a in invasion and metastasis of pancreatic cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(03):352.[doi:10.3969/j.issn.1672-271X.2017.04.005]
[3]朱寻,陆建平.小成像视野薄层靶扫描胰腺动脉CT增强造影对自身免疫性胰腺炎与胰腺癌的鉴别诊断[J].医学研究与战创伤救治(原医学研究生学报),2018,20(05):506.[doi:10.3969/j.issn.1672-271X.2018.05.013]
ZHU Xun,LU Jian-ping.Differential diagnosis of autoimmune pancreatitis and pancreatic cancer in small imaging field of vision pancreatic artery CT enhanced angiography[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(03):506.[doi:10.3969/j.issn.1672-271X.2018.05.013]